跳至主要内容
临床试验/CTRI/2025/10/096459
CTRI/2025/10/096459尚未招募不适用

A randomised controlled clinical study to evaluate the effect of sarvanga tvagadi alepa in the management of amavata w.s.r to rheumatoid arthritis

Sushmitha K1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年11月10日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Parametric data analysed before and after the study using paired t test for within the group and unpaired t test for between the group.

研究概览

简要总结

• This is an open label comparative clinical study with pre-test and post-test design where minimum 30 patients of Amavata of either gender will be selected based on diagnostic and inclusion criteria and randomly distributed between Agnichikitsa alepa and Sarvanga Tvagadi alepa group.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients fulfilling diagnostic criteria.

排除标准

  • All connective tissue disorders other than Rheumatoid arthritis.
  • Patients with any other systemic illness which will hamper treatment.
  • All patients who are allergic to alepa.

结局指标

主要结局

Parametric data analysed before and after the study using paired t test for within the group and unpaired t test for between the group.

时间窗: 14 days

Non parametric data analysed before and after the study using Wilcoxon signed rank test for within the group and Mann Whitney test for between the group.

时间窗: 14 days

The signs and symptoms will be assessed before treatment on 0th day and after the treatment on 7th day and after 14 days of follow up based on subjective and objective parameters.

时间窗: 14 days

次要结局

未报告次要终点

研究者

发起方
Sushmitha K
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Sushmitha K

shri dharmasthala manjunatheshwara college of ayurveda hospital and research centre kuthpady udupi

研究点 (1)

Loading locations...

相似试验